← Back to Fund Radar

Fund page

SMART GESTION FLEXIBLE, FI

Category
—
Latest period
H2 2025
Positions
42

Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)

Full portfolio

Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.

42
Company Type Country Weight Price
BANCO INVERSIS, S.A. ES0000012O67 · EUR Adquisicion Temporal Activos ES 8.07% —
BANCO INVERSIS, S.A. ES0000012O59 · EUR Adquisicion Temporal Activos ES 8.07% —
BANCO INVERSIS, S.A. ES0L02602065 · EUR Adquisicion Temporal Activos ES 8.07% —
BANCO INVERSIS, S.A. ES0000012N35 · EUR Adquisicion Temporal Activos ES 8.07% —
BANCO INVERSIS, S.A. ES0000012L60 · EUR Adquisicion Temporal Activos ES 8.07% 36.02 USD
BANCO INVERSIS, S.A. ES0000012411 · EUR Adquisicion Temporal Activos ES 8.07% —
BUONI POLIENNALI DEL IT0005544082 · EUR Deuda Publica Cotizada Mas 1 Anio IT 2.13% —
Sidecu ES0305063010 · EUR Renta Fija Cotizada Mas 1 Anio ES 1.98% —
ACCIONES|Neinor Homes SLU ES0105251005 · EUR Renta Variable Cotizada ES 1.61% 16.78 EUR
FED REPUBLIC OF BRAZ US105756BN96 · BRL Deuda Publica Cotizada Mas 1 Anio US 1.58% —
GAP INC/THE USU36547AF18 · USD Renta Fija Cotizada Mas 1 Anio US 1.28% —
ACCIONES|Accs. Grifols S.A. ES0171996087 · EUR Renta Variable Cotizada ES 1.26% 10.18 EUR
Petroleos Mexicanos XS1568888777 · EUR Renta Fija Cotizada Mas 1 Anio XS 1.22% —
ACCIONES|IncytCor US45337C1027 · USD Renta Variable Cotizada US 1.18% 113.07 USD
ACCIONES|Pfizer Inc US7170811035 · USD Renta Variable Cotizada US 1.16% 29.58 USD
ACCIONES|AUDAX RENOVABLES ES0136463017 · EUR Renta Variable Cotizada ES 1.10% 1.04 EUR
BRITISH TELECOMMUNIC XS0306772699 · GBP Renta Fija Cotizada Mas 1 Anio XS 1.09% —
ACCIONES|ROCHE HOLDING CH0012032048 · CHF Renta Variable Cotizada CH 1.08% 57.14 USD
TELECOM ITALIA SPA XS2581393134 · EUR Renta Fija Cotizada Mas 1 Anio XS 1.07% 5.62 EUR
ACCIONES|Grupo Ezentis SA ES0172708234 · EUR Renta Variable Cotizada ES 0.98% 0.07 EUR
ABERTIS INFRAESTRUCT XS1967635977 · EUR Renta Fija Cotizada Mas 1 Anio XS 0.94% —
BANK OF AMERICA CORP XS1602547264 · EUR Renta Fija Cotizada Mas 1 Anio XS 0.94% 51.23 USD
ACCIONES|Merck & Co. Inc. US58933Y1055 · USD Renta Variable Cotizada US 0.93% 145.95 USD
DEUTSCHE BANK AG DE000DL19WL7 · EUR Renta Fija Cotizada Mas 1 Anio DE 0.92% 29.33 EUR
ROMANIA XS2434895632 · EUR Deuda Publica Cotizada Mas 1 Anio XS 0.92% 0.24 RON
ACCIONES|Bristol - Myers Sqi US1101221083 · USD Renta Variable Cotizada US 0.91% 59.75 USD
BUONI POLIENNALI DEL IT0005534141 · EUR Deuda Publica Cotizada Mas 1 Anio IT 0.76% —
ACCIONES|Sanofi - Synthelabo FR0000120578 · EUR Renta Variable Cotizada FR 0.74% 71.94 EUR
FRANCE (GOVT OF) FR001400OHF4 · EUR Deuda Publica Cotizada Mas 1 Anio FR 0.72% 70.02 EUR
UNITED KINGDOM GILT GB00BPSNBB36 · GBP Deuda Publica Cotizada Mas 1 Anio GB 0.72% —
ACCIONES|Carrefour FR0000120172 · EUR Renta Variable Cotizada FR 0.68% 16.61 EUR
ACCIONES|Puig SM ES0105777017 · EUR Renta Variable Cotizada ES 0.68% 19.57 EUR
ACCIONES|Nokia FI0009000681 · EUR Renta Variable Cotizada FI 0.59% 8.42 EUR
ACCIONES|OC Oerlikon Corp AG CH0000816824 · CHF Renta Variable Cotizada CH 0.57% 5.94 CHF
ACCIONES|Qumicia Y Minera Chi US8336351056 · USD Renta Variable Cotizada US 0.51% 60.20 USD
ACCIONES|V Tecnology Co Ltd JP3829900004 · JPY Renta Variable Cotizada JP 0.29% 5710.00 JPY
ACCIONES|Under Armour INC US9043111072 · USD Renta Variable Cotizada US 0.28% 4.74 USD
ACCIONES|AMS AG AT0000A3EPA4 · CHF Renta Variable Cotizada AT 0.26% 17.83 CHF
ACCIONES|Naturhouse Health, S ES0105043006 · EUR Renta Variable Cotizada ES 0.05% 2.24 EUR
ACCIONES|Almirall SA ES0157097017 · EUR Renta Variable Cotizada ES 0.03% 10.02 EUR
ACCIONES|APERAM LU0569974404 · EUR Renta Variable Cotizada LU 0.02% 37.60 EUR
ACCIONES|Thungela Resources L ZAE000296554 · GBP Renta Variable Cotizada ZA 0.00% 12799.00 ZAc

This period's moves

H2 2025 vs H1 2025 (estimated)

New: 9 Exits: 11 Increases: 1 Cuts: 20
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

View company page →
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

View company page →
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

View company page →
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

View company page →
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

Grupo Financiero Galicia S.A., a financial service holding company, provides various financial products and services to individuals and companies in Argentina. The company operates through Bank, Naranja X, Insurance, and Other Businesses segments. It offers savings, checking, and time deposits; and credit and debit cards. The company also provides personal loans, salary advance, express loans, AfterPay, Buy Now Pay Later, flexible loans, and overdrafts for individuals; and immediate loans, discount of electronic credit invoice and e-checks, pledge and mortgage loans, Sociedad de Garantía Recíproca loans, Socios de valor, productive line, leasing, and purchase of agricultural inputs for companies. In addition, the company offers life, home, personal accident, robbery, cars, and other insurance products; fixed term, traditional fixed term, and purchasing value unit investment products; custody of securities; purchase and sale of foreign currency; private banking; and fixed income products, stocks, CEDEARs, secured loans, mutual funds, stock promissory note, structured solutions, and primary issuances; foreign trade; and capital market and investment banking. Further, it provides online banking services. Grupo Financiero Galicia S.A. was founded in 1905 and is based in Buenos Aires, Argentina.

View company page →
+ BANCO INVERSIS, S.A.

Enters the portfolio at 8.07% weight.

View company page →
+ ACCIONES|Merck & Co. Inc.

Enters the portfolio at 0.93% weight.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

View company page →
+ ACCIONES|Bristol - Myers Sqi

Enters the portfolio at 0.91% weight.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

View company page →
+ ACCIONES|Sanofi - Synthelabo

Enters the portfolio at 0.74% weight.

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

View company page →
− BANCO INVERSIS, S.A.

Leaves the portfolio; it was 14.39% of weight.

− ACCIONES|Covestro AG

Leaves the portfolio; it was 2.26% of weight.

Covestro AG operates as a supplier of polymer materials and application solutions. The company operates in two segments, Performance Materials, and Solutions & Specialties. The Performance Materials segment develops, produces, and supplies high-performance materials, such as polyurethanes and polycarbonates, and base chemicals, which include diphenylmethane diisocyanate (MDI), toluene diisocyanate, long-chain polyols, and polycarbonate resins for use in furniture and wood processing, construction, automotive, and transportation industries, as well as roof structures, insulation for buildings and refrigerators, mattresses, car seats, and other applications. The Solutions & Specialties segment comprises a range of polymer products, including polycarbonates, precursors for coatings and adhesives, MDI specialties and polyols, thermoplastic polyurethanes, specialty films, and elastomers that are used in automotive and transportation, electrical, electronics and household appliances, construction, and healthcare industries, as well as composite resins for solar panel frames, precursors for coatings and adhesives, specialty films, laptop cases, floodlights, and electric vehicle batteries. It markets its products through trading houses and distributors. It operates in Europe, the Middle East, Africa, Latin America, the United States, Canada, and the People's Republic of China. The company was founded in 1863 and is headquartered in Leverkusen, Germany. As of December 10, 2025, Covestro AG operates as a subsidiary of XRG P.J.S.C.

− Gestamp Auto

Leaves the portfolio; it was 1.19% of weight.

Gestamp Automoción, S.A. designs, develops, and manufactures metal components for the automotive industry in Western Europe, Eastern Europe, Mercosur, North America, and Asia. The company offers body-in-white products, large components and assembly parts, such as bonnets, roofs, doors, and mudguards, as well as other surface and assembly parts for use in creation of visible exterior skin of vehicles; and structural and crash-related elements, including floors, pillars, rails, and wheel arches. It also provides chassis parts comprising under body of vehicles and includes systems, frames and related parts, such as front and rear axles and couplings, control arms, and integrated couplings; hinges, door checks, electrical systems, and powered systems. In addition, the company offers hydraulic presses and dies in the areas of hot stamping, cold stamping, hydroforming, and try out of tools. Further, it serves vehicle manufacturers. Gestamp Automoción, S.A. was incorporated in 1997 and is headquartered in Madrid, Spain. Gestamp Automoción, S.A. is a subsidiary of Gestamp 2020, S.L.

− ACCIONES|American Eagle Outfi

Leaves the portfolio; it was 0.96% of weight.

American Eagle Outfitters, Inc. operates as a multi-brand specialty retailer in the United States and internationally. It provides jeans, apparel and accessories, and personal care products for women and men under the American Eagle brand; and intimates, apparel, activewear, and swim collections under the Aerie and OFFLINE by Aerie brands. The company also offers menswear products under the Todd Snyder New York brand; and fashion clothing and accessories under the Unsubscribed brand. It sells its products through its own and licensed retail stores, concession-based shops-within-shops, wholesale markets, and online marketplaces; and digital channels, such as www.ae.com, www.aerie.com, www.toddsnyder.com, and www.unsubscribed.com. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

− ACCIONES|Barrick Gold Corp

Leaves the portfolio; it was 0.94% of weight.

Barrick Mining Corporation engages in the exploration, development, production, and sale of mineral properties. It explores for gold, copper, silver, and energy materials. The company was formerly known as Barrick Gold Corporation and changed its name to Barrick Mining Corporation in May 2025. Barrick Mining Corporation was founded in 1983 and is based in Toronto, Canada.

− ACCIONES|B2Gold Corp

Leaves the portfolio; it was 0.82% of weight.

B2Gold Corp. operates as a gold producer company in Canada. The company operates the Fekola Mine in Mali; the Masbate Mine in the Philippines; the Otjikoto Mine in Namibia; the Goose Mine in Canada. It also owns 100% interest in the Gramalote gold project in Colombia. In addition, the company has a portfolio of other evaluation and exploration assets in Mali, Canada and Finland. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

− ACCIONES|Alibaba Group Hldng

Leaves the portfolio; it was 0.76% of weight.

Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses in the People's Republic of China and internationally. It operates through the Alibaba China E-Commerce Group, Alibaba International Digital Commerce Group, Cloud Intelligence Group, and All Others segments. The Alibaba China E-commerce Group segment operates Taobao and Tmall, which are digital retail platforms; Taobao Instant Commerce, a local services and on-demand delivery platform; 1688.com, a domestic wholesale marketplace; and Xianyu, a consumer-to-consumer community and marketplace for idle goods. Its Alibaba International Digital Commerce Group segment includes AliExpress, a global e-commerce platform; Trendyol, an e-commerce platform in Turkey; Lazada, an e-commerce platform in Southeast Asia; Daraz, an e-commerce platform in South Asia, primarily in Pakistan and Bangladesh; and Alibaba.com, an integrated international online wholesale marketplace. The Cloud Intelligence Group segment offers a suite of cloud services based on infrastructure-as-a-service, platform-as-a-service, and model-as-a-service. Its All Others segment comprises Amap, a provider of mobile digital maps, navigation, and real-time traffic information in China; Cainiao, which provides logistics solutions; Youku, an online long-form video platform in China; Freshippo, a retail platform for groceries and fresh goods; and Alibaba Health, a pharmaceutical and healthcare services platform. Alibaba Group Holding Limited was incorporated in 1999 and is based in Hangzhou, China.

View company page →
− ACCIONES|Baidu Inc

Leaves the portfolio; it was 0.68% of weight.

− ACCIONES|Tecnicas Reunidas

Leaves the portfolio; it was 0.50% of weight.

Técnicas Reunidas, S.A., an engineering and construction company, designs and manages industrial plant projects worldwide. It operates through Upstream & Refining, Natural gas, Petrochemical, Low-carbon technologies, and Other segments. The Refining segment offers management, engineering, procurement, construction and commissioning services for facilities along the entire value chain to produce fuels. The Natural gas segment provides direction, management, engineering, procurement, construction and commissioning services for facilities throughout the supply chain, from natural gas production to regasification terminals; and treatment and processing plants, compressor and liquefaction stations, storage tanks, and final regasification facilities. The Petrochemical segment provides direction, management, engineering, procurement, construction and startup services for facilities dedicated to the production of basic chemical materials used in water distribution, pharmaceuticals, health, food, energy efficiency in buildings and transport systems, and others. The Low-carbon technologies segment offers hydrogen, carbon capture and storage, circular economy and bioproducts; produces biomethane and converts biomass and waste into fuels, biodiesel, biokerosene, chemicals, and power and steam generation. The Other segment offers water treatment, port infrastructures, and oil production. In addition, the company is involved in real estate-related activities, consultancy and assistance in international engineering projects, project execution, and machinery wholesale business. Técnicas Reunidas, S.A. was formerly known as Lummus Española, S.A. and changed its name to Técnicas Reunidas, S.A. in 1972. The company was incorporated in 1960 and is headquartered in Madrid, Spain.

View company page →
− ACCIONES|Maple Leaf Foods Inc

Leaves the portfolio; it was 0.48% of weight.

Maple Leaf Foods Inc., together with its subsidiaries, operates as a protein-focused consumer packaged goods company in Canada, the United States, Japan, Korea, the Philippines, China, and internationally. It offers fresh and frozen poultry, bacon, hams, wieners, meat snacks, a variety of delicatessen products, specialty sausages, a line of cooked meats, sliced meats, cooked sausage products, lunch kits, and canned meats; processed chicken products comprising fully cooked chicken breasts and wings; and a range of plant-based products, including tempeh and plant-based chicken, sausages, wieners, bacon, grounds, burgers, deli meat, cheeses, and frozen appetizers under the Maple Leaf, Maple Leaf Prime, Schneiders, Mina, Greenfield Natural Meat Co., Fantino & Mondello, Grab'N Snack, Lunch Mate, LightLife, Field Roast, Chao, Swift Premium, Hygrade, Mitchell's Gourmet, Larsen, and Shopsy's brands, as well as private label brands. The company was founded in 1836 and is headquartered in Mississauga, Canada.

− ACCIONES|Chiyoda Corp

Leaves the portfolio; it was 0.43% of weight.

Chiyoda Corporation engages in the integrated engineering business in Japan, the United States, and internationally. It provides consulting, planning, design, construction, procurement, commissioning, and maintenance services for various plants, industrial and residential, and facilities related to gas, electricity, petroleum, petrochemical, chemical, pharmaceutical, pollution prevention, environment and disaster preservation, and others. The company also explores oil, gas, and other mineral resources, as well as invests in and finances exploration activities; design, procurement, and installation of equipment and machinery; engages in civil engineering, construction, and piping work; commissioning; and all other related businesses. Chiyoda Corporation was incorporated in 1948 and is headquartered in Yokohama, Japan.

▲ ACCIONES|Pfizer Inc

Goes from 0.72% to 1.16%.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

View company page →
▼ ACCIONES|Naturhouse Health, S

Goes from 1.70% to 0.05%.

Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and food and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. In addition, the company engages in the production, preparation, and marketing of dietary products; and marketing of medicinal herbs and natural cosmetics. It sells its products through directly operated stores and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. and changed its name to Naturhouse Health, S.A. Naturhouse Health, S.A. was incorporated in 1991 and is based in Madrid, Spain. Naturhouse Health, S.A. is a subsidiary of Kiluva S.A.

View company page →
▼ ACCIONES|APERAM

Goes from 1.04% to 0.02%.

Aperam S.A., together with its subsidiaries, produces and sells stainless steel and alloy products worldwide. The company operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel, flat stainless and electrical steel, and special carbon products. It also produces specialty grades alloys and specialties. In addition, the company engages in tubes business, as well as provision of value added and customized steel solutions. Further, it collects, trades, processes, and recycles stainless steel scrap and high-performance alloys. The company serves aerospace, automotive, construction, medical, and oil and gas industries. It distributes its products through a network of steel service centers, transformation facilities, and sales offices. The company was incorporated in 2010 and is headquartered in Luxembourg, Luxembourg.

View company page →
▼ ACCIONES|Grupo Ezentis SA

Goes from 1.87% to 0.98%.

Grupo Ezentis, S.A. operates telecommunications and energy infrastructures. The company provides fixed and radio communications services, including consulting, design, planning, installation, commissioning, and maintenance of communications systems; undertakes outdoor and indoor projects, such as football fields, airports, tunnels, subways, bus stations, and shopping centers; industrial installation services in logistics and production centers; and new construction, renovations, and expansions. It also undertakes construction, rehabilitation, and expansion projects for centers and buildings; comprehensive maintenance services for buildings, production centers, logistics platforms, commercial premises, and hotels; and services for improving the energy efficiency of facilities. In addition, it engages in development, installation, and integration of interactive audiovisual communication projects and devices. Ezentis, S.A. was incorporated in 1959 and is based in Madrid, Spain.

View company page →
▼ BUONI POLIENNALI DEL

Goes from 2.70% to 2.13%.

View company page →
▼ ACCIONES|AUDAX RENOVABLES

Goes from 1.54% to 1.10%.

Audax Renovables, S.A. engages in the generation and supply of renewable electricity and gas in Spain, Portugal, the Netherlands, Hungary, Italy, Poland, Germany, and France. It has a portfolio of wind and photovoltaic farms with a capacity of 1,037 megawatts. The company also sells electricity and gas. Audax Renovables, S.A. was incorporated in 2000 and is based in Badalona, Spain. Audax Renovables, S.A. operates as a subsidiary of Electrica Nuriel, S.L.

View company page →
▼ ACCIONES|Qumicia Y Minera Chi

Goes from 0.94% to 0.51%.

Sociedad Química y Minera de Chile S.A. produces and sells specialty plant nutrients, and iodine and its derivatives in Chile, Latin America, the Caribbean, Europe, North America, Asia, and internationally. It offers potassium nitrate, sodium nitrate, specialty blends, and other specialty fertilizers under the Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, Prop, and Prohydric brands. The company also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders. In addition, it produces lithium carbonate and lithium hydroxide which are used in the production of cathode material for, secondary batteries; lithium chloride; and basic lithium chemicals and lithium derivatives used in lubricating greases for heat-resistant glass, chips for the ceramic and glazing industry, and air conditioning chemicals, as well as other pharmaceutical syntheses and metal alloys. Further, the company produces potassium sulfate; and potassium chloride which are used to nourish various crops. Additionally, it produces and markets industrial chemicals, such as sodium nitrate mainly used in the production of glass and explosives, metal processing and recycling, and production of insulating materials and adhesives; potassium nitrate used as a raw material to produce frits and special ty glass, as well as in the enamel, metal treatment, and pyrotechnic sectors; solar salts used as a thermal storage medium in solar power generation plants; and potassium chloride as an additive in oil drilling and food processing sectors, as well as sells third-party fertilizers. Sociedad Química y Minera de Chile S.A. was founded in 1926 and is headquartered in Santiago, Chile.

View company page →
▼ FED REPUBLIC OF BRAZ

Goes from 1.93% to 1.58%.

View company page →
▼ GAP INC/THE

Goes from 1.60% to 1.28%.

View company page →
▼ TELECOM ITALIA SPA

Goes from 1.36% to 1.07%.

Telecom Italia S.p.A., together with its subsidiaries, engages in the fixed and mobile telecommunications services and products for individuals, households, and supports small and medium-sized enterprises in Italy and internationally. It operates through Domestic, Brazil, and Other Operations segments. The company offers telephone and internet services, as well as products managed and developed in landline and mobile for individuals and families; voice, data, and internet services and products; and information and communications technology solutions for top, public sector and large account customers. It also provides connectivity services; mobile phone services and fiber optic data transmission using IP technology and residential broadband services; and internet of things services. Telecom Italia S.p.A. was incorporated in 1908 and is headquartered in Rome, Italy.

View company page →
▼ ACCIONES|Puig SM

Goes from 0.97% to 0.68%.

Puig Brands, S.A. operates in the beauty and fashion industry in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company operates through three segments: Fragrance and Fashion, Makeup, and Skincare. The Fragrance and Fashion segment designs, develops, and markets fragrances in various forms, including eau de parfum sprays and colognes, lotions, powders, creams, candles, and soaps, that are based on a particular fragrance, as well as clothing, footwear and accessories under the Carolina Herrera, Jean Paul Gaultier, Nina Ricci, Rabanne, Byredo, Christian Louboutin, Dries Van Noten, L'Artisan Parfumeur, Penhaligon's, Adolfo Domínguez, and Banderas brands. The Makeup segment engages in the creation, marketing, and sale of a range of cosmetic products, such as foundations, concealers, lipsticks, lip glosses, eyeliners, blushes, mascaras, and eyeshadows under the Carolina Herrera, Charlotte Tilbury, Rabanne, Byredo, Christian Louboutin, and Dries Van Noten brands. The Skincare segment offers cleansers, toners, moisturizers, serums, body care, exfoliators, acne, and oil correctors, facial masks, and sun care products under the Uriage, Apivita, Dr.Barbara Sturm, Kama Ayurveda, Loto del Sur, and Charlotte Tilbury brands. It sells its products in department stores, warehouses, pharmacies, drug stores, travel retail, spas, and Puig's own shops through digital channels, brands' own e-commerce, and distributors. The company was incorporated in 1914 and is based in Barcelona, Spain. Puig Brands, S.A. is a subsidiary of Puig, S.L.

View company page →
▼ BRITISH TELECOMMUNIC

Goes from 1.37% to 1.09%.

View company page →
▼ ACCIONES|Accs. Grifols S.A.

Goes from 1.54% to 1.26%.

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

View company page →
▼ Petroleos Mexicanos

Goes from 1.49% to 1.22%.

View company page →
▼ BANK OF AMERICA CORP

Goes from 1.19% to 0.94%.

Bank of America Corporation, through its subsidiaries, provides various financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates through four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, checking accounts, and investment accounts and products; credit and debit cards; residential mortgages and home equity loans; and direct and indirect loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, and underwriting and advisory services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.

View company page →
▼ FRANCE (GOVT OF)

Goes from 0.97% to 0.72%.

View company page →
▼ ABERTIS INFRAESTRUCT

Goes from 1.19% to 0.94%.

View company page →
▼ DEUTSCHE BANK AG

Goes from 1.17% to 0.92%.

Deutsche Bank Aktiengesellschaft, a stock corporation, provides corporate and investment banking, private clients, and asset management products and services in Germany, the United Kingdom, the rest of Europe, the Americas, the Asia-Pacific, the Middle East, and Africa. It operates through Corporate Bank, Investment Bank, Private Bank, and Asset Management segments. The Corporate Bank segment offers cash management services, such as integrated payments and FX solutions; trade finance and lending offerings, including documentary and guarantee business, and structured trade finance and lending; and depository receipts, corporate trust, document custody, and securities services. The Investment Bank segment provides financing solutions in industries and asset classes; institutional sales, trading, and structuring in foreign exchange, rates, emerging markets, and credit trading; liquidity, market making services, and specialized risk management solutions for fixed income and currencies products; and advisory and financial products and services. This segment is also involved in the mergers and acquisitions business; and capital markets businesses in debt and equity. The Private Bank segment offers a range of payment and account services, and credit and deposit products, as well as investment advice, and postal and parcel services; and planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The Asset Management segment provides access to investment capabilities in active and passive asset classes comprising Xtrackers range and alternatives; and access to private equity, private credit, real estate, and infrastructure. Deutsche Bank Aktiengesellschaft was incorporated in 1870 and is headquartered in Frankfurt am Main, Germany.

View company page →
▼ ACCIONES|OC Oerlikon Corp AG

Goes from 0.81% to 0.57%.

OC Oerlikon Corporation AG provides surface engineering, polymer processing, and advanced manufacturing services in Europe, the Americas, and the Asia-Pacific. The company operates through The Oerlikon Division and The Barmag Division. It offers actuation systems, aircraft interior, cold plates, engine fan and compressors, engine hot section, heat exchanger, hydraulic systems, landing gears, RF components, and rocket engine components for aerospace sector. The company also provides brake and safety systems, drive train, engine systems, exhaust systems, exterior, green hydrogen, heat exchangers and EGR coolers, interior, lighting, peripherals and design parts, piping and tubing systems, steering and suspension, thermoelectrical isolation system, and transmissions for automotive sector. In addition, it offers boiler, gas turbines, hydro turbines, green hydrogen, oil and gas, steam turbines, and wind turbines for energy sector; cutting, die casting, metal forming, and plastic processing for tooling industry; and artificial joints, dental implants/abutments, medical, minimally invasive surgical instruments, spine implants, surgical instruments, and veterinary implants for medical sector. Further, the company provides various products for agriculture, beauty and personal care, consumer goods, electronics, engineering, food and packaging, logistic and environmental, metal forming and processing, mining and heavy machinery, pulp, paper and printing, and semiconductor applications; and Luxury and semiconductor products. It offers its surface solutions under Oerlikon Balzers, Oerlikon Metco, Oerlikon AM, Oerlikon Riri, and Oerlikon Fineparts brand names; and provides friction systems, turbine components, and thermoelectrical insulation systems, as well as coating equipment and components. OC Oerlikon Corporation AG was founded in 1876 and is headquartered in the Pfäffikon, Switzerland.

View company page →
▼ BUONI POLIENNALI DEL

Goes from 0.97% to 0.76%.

View company page →
▼ ACCIONES|Under Armour INC

Goes from 0.48% to 0.28%.

Under Armour, Inc., together with its subsidiaries, engages designs, developing, marketing, and distributing performance apparel, footwear, and accessories for men, women, and youth. The company provides its apparel in compression, fitted, and loose fit types. It also offers footwear products for running, training, basketball, cleated sports, recovery, and outdoor applications, as well as for casual use. In addition, the company provides accessories, which include gloves, bags, headwear, and socks. It primarily offers its products under the UNDER ARMOUR, ARMOUR, HEATGEAR, COLDGEAR, HOVR, UA, PROTECT THIS HOUSE, I WILL, ARMOUR FLEECE, and ARMOUR BRA brands. The company sells its products through wholesale channels, including national and regional sporting goods chains, independent and specialty retailers, department store chains, mono-branded Under Armour retail stores, institutional athletic departments, and leagues and teams, as well as independent distributors; and directly to consumers through its own brand and factory house retail stores and e-commerce websites. It operates in the United States, Canada, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company was incorporated in 1996 and is headquartered in Baltimore, Maryland.

View company page →

Fixed income

Declared FI exposure
6.5 M €
% of portfolio
64.7%
Positions
20
Issuers
13
Sovereign: 688,686 € Corporate: 955,018 € Repos / treasury management: 4.9 M €

Maturity ladder

Observed contractual maturity of each position, repos excluded. Matured/≤3 months includes bonds maturing in the first days after the period close.

1-2 years · 11.6%2-5 years · 49.5%5-10 years · 18.7%> 10 years · 20.1%
Maturity Positions Exposure %
Matured or ≤3 months 0 0 € 0.0%
3-6 months 0 0 € 0.0%
6-12 months 0 0 € 0.0%
1-2 years 2 190,550 € 11.6%
2-5 years 6 813,875 € 49.5%
5-10 years 2 308,140 € 18.7%
> 10 years 4 331,139 € 20.1%
Unknown 0 0 € 0.0%

Top issuers

The 10 issuers with the largest declared exposure in this fund, repos excluded.

Issuer Type ISINs Exposure Next maturity
Repubblica Italiana Sovereign 2 292,013 € 2033-11-01
SIDECU SA Corporate 1 199,793 € 2028-03-18
FED REPUBLIC OF BRAZ Sovereign 1 159,214 € 2028-01-10
GAP INC/THE Corporate 1 129,654 € 2029-10-01
PETROLEOS MEXICANOS Corporate 1 123,725 € 2028-02-21
BRITISH TELECOMMUNIC Corporate 1 109,807 € 2037-06-23
TELECOM ITALIA SPA Corporate 1 108,080 € 2028-02-15
ABERTIS INFRAESTRUCT Corporate 1 95,305 € 2027-09-27
BANK OF AMERICA CORP Corporate 1 95,245 € 2027-05-04
DEUTSCHE BANK AG Corporate 1 93,409 € 2028-02-23

Top instruments

The 10 instruments with the largest declared exposure. No yield, IRR or rating: there's no reliable data to compute them.

ISIN Coupon Maturity Exposure
IT0005544082 Repubblica Italiana 4.35% 2033-11-01 215,165 €
ES0305063010 SIDECU SA 8.00% 2028-03-18 199,793 €
US105756BN96 FED REPUBLIC OF BRAZ 10.25% 2028-01-10 159,214 €
USU36547AF18 GAP INC/THE 3.63% 2029-10-01 129,654 €
XS1568888777 PETROLEOS MEXICANOS 4.88% 2028-02-21 123,725 €
XS0306772699 BRITISH TELECOMMUNIC 6.38% 2037-06-23 109,807 €
XS2581393134 TELECOM ITALIA SPA 6.88% 2028-02-15 108,080 €
XS1967635977 ABERTIS INFRAESTRUCT 2.38% 2027-09-27 95,305 €
XS1602547264 BANK OF AMERICA CORP 1.78% 2027-05-04 95,245 €
DE000DL19WL7 DEUTSCHE BANK AG 1.88% 2028-02-23 93,409 €

Currencies

Fixed-income exposure by instrument currency.

Currency Exposure %
EUR 6.1 M € 92.8%
GBP 182,045 € 2.8%
BRL 159,214 € 2.4%
USD 129,654 € 2.0%

This period's fixed-income moves

Compares the current fixed-income portfolio with the previous period, by ISIN. An exit that coincides with maturity isn't a sale: the bond reached its contractual date.

New positions: 0 Exits at maturity: 0 Exits not explained by maturity: 1
− Gestamp Auto

Leaves the portfolio; it was 1.19% of weight.

Disclaimer

This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.